Does TOBRAMYCIN Cause Neoplasm malignant? 11 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 11 reports of Neoplasm malignant have been filed in association with TOBRAMYCIN (TOBRAMYCIN). This represents 0.1% of all adverse event reports for TOBRAMYCIN.
11
Reports of Neoplasm malignant with TOBRAMYCIN
0.1%
of all TOBRAMYCIN reports
2
Deaths
5
Hospitalizations
How Dangerous Is Neoplasm malignant From TOBRAMYCIN?
Of the 11 reports, 2 (18.2%) resulted in death, 5 (45.5%) required hospitalization.
Is Neoplasm malignant Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TOBRAMYCIN. However, 11 reports have been filed with the FAERS database.
What Other Side Effects Does TOBRAMYCIN Cause?
Off label use (1,467)
Death (888)
Cough (738)
Dyspnoea (706)
Pneumonia (700)
Hospitalisation (688)
Condition aggravated (669)
Cystic fibrosis (646)
Infective pulmonary exacerbation of cystic fibrosis (504)
Drug ineffective (453)
What Other Drugs Cause Neoplasm malignant?
RANITIDINE (10,648)
ADALIMUMAB (2,028)
APIXABAN (1,772)
ETANERCEPT (1,616)
METHOTREXATE (1,041)
TOFACITINIB (1,020)
RITUXIMAB (929)
INFLIXIMAB (892)
ABATACEPT (727)
RISANKIZUMAB-RZAA (715)
Which TOBRAMYCIN Alternatives Have Lower Neoplasm malignant Risk?
TOBRAMYCIN vs TOBRAMYCIN\TOBRAMYCIN
TOBRAMYCIN vs TOCILIZUMAB
TOBRAMYCIN vs TOCILIZUMAB-AAZG
TOBRAMYCIN vs TOCOPHEROL
TOBRAMYCIN vs TOFACITINIB